A Prospective, Randomised, Double-blind, Placebo Controlled Study to assess the Role of Aloe Vera with or without Glucosamine & Chondroitin in Patients with Symptomatic Osteoarthritis of Knees

ISRCTN ISRCTN01562001
DOI https://doi.org/10.1186/ISRCTN01562001
Protocol serial number N0020180355
Sponsor Record Provided by the NHSTCT Register - 2007 Update - Department of Health
Funder Barking, Havering and Redbridge Hospitals NHS Trust (UK)
Submission date
28/09/2007
Registration date
28/09/2007
Last edited
24/08/2015
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Musculoskeletal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Kuntal Chakravarty
Scientific

Consultant Rheumatologist
Rheumatology Department
Harold Wood Hospital
Gubbins Lane
Romford
RM3 0BE
United Kingdom

Study information

Primary study designInterventional
Study designRandomised double-blind placebo-controlled trial
Secondary study designRandomised controlled trial
Study type Participant information sheet
Scientific titleA Prospective, Randomised, Double-blind, Placebo Controlled Study to assess the Role of Aloe Vera with or without Glucosamine & Chondroitin in Patients with Symptomatic Osteoarthritis of Knees
Study objectivesTo evaluate the role of aloe vera with or without glucosamine and Chondroitin in patients with symptomatic osteoarthritis of knees.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedMusculoskeletal Diseases: Osteoarthritis of the knee
InterventionAloe vera with or without glucosamine and Chondroitin
Intervention typeDrug
PhaseNot Applicable
Drug / device / biological / vaccine name(s)Aloe vera with or without glucosamine and Chondroitin
Primary outcome measure(s)

1. Assessment and comparison of overall symptoms including pain, range of motions and variables such as swelling etc in the affected joints and other measures of functional aspects of the joint
2. Assessment of Quality of life

Key secondary outcome measure(s)

Not provided at time of registration

Completion date30/04/2008

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexNot Specified
Key inclusion criteria1. Age between 18 - 80 years
2. Symptoms of episodic or continuous pain in the affected knee joint for 6 weeks
3. Diagnosis of OA of Knee made according to ACR criteria (knee pain and radiographic osteophytes and at least any one of the following 3 items: a) Age > 50 years b) Morning Stiffness < 30 minutes in duration c) Crepitus on motion
Key exclusion criteria1. Any contra indication to Aloe Vera /Glucosamine/Chondroitin
2. Current Use or use within 3 months of screening of aloe vera/Glucosamine/Chondroitin
3. Current or Previous history of oral steroid or injection in the study joint within 3 months
4.Current or previous history of Intra articular Synvisc or Hyalgan therapy
5. Previous history of NSAID topical application within the last 3 months
6. Any previous history of Knee surgery including Menisectomy / patellectomy etc
7. Presence of Inflammatory Arthritis
8. Presence of significant hip disease on the side of symptomatic knee
Date of first enrolment01/04/2006
Date of final enrolment30/04/2008

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

Harold Wood Hospital
Romford
RM3 0BE
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes